SNTI · ISSUER CIK 1854270
Senti Biosciences Holdings, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Senti Biosciences Holdings, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 23, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 202616:38 | Oct 21, 2026 | SNTI | Pres. & Chief Med. & Dev. Off. | F · Tax | — | −19,953 | 54,890 | -27% | — | ||
| Oct 23, 202616:37 | Oct 21, 2026 | SNTI | CEO, Director | F · Tax | — | −157,312 | 482,271 | -25% | — |